Kairos Pharma, LTD.
KAPA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962011
No open-market purchases or sales by Kairos Pharma, LTD. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $371.1K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Kairos Pharma, LTD. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 8 | 10 | +2 |
| Shares | 1.58M | 218.7K | −1.36M (−86.1%) |
| Value | $1.46M | $172.9K | −$1.29M (−88.2%) |
New holders (5)
Institutions that held Kairos Pharma, LTD. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 62,746 | $44.5K | 0.00% |
| Two Sigma Securities, LLC | 13,555 | $9.61K | 0.00% |
| HRT Financial LP | 13,239 | $9.00K | 0.00% |
| Citigroup Inc | 5,499 | $3.90K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,797 | $2.69K | 0.00% |
Sold out (3)
Institutions that held Kairos Pharma, LTD. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Armistice Capital, LLC | 1,404,000 | $1.31M |
| Scientech Research LLC | 48,198 | $45.1K |
| Citadel Advisors LLC | 13,230 | $12.4K |